Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2000
10/05/2000CA2368909A1 48 human secreted proteins
10/05/2000CA2368881A1 50 human secreted proteins
10/05/2000CA2368760A1 Flint polypeptide analogs
10/05/2000CA2368719A1 50 human secreted proteins
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368657A1 Thrombospondin-2 and uses thereof
10/05/2000CA2368641A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000CA2368638A1 Method for pr-39 peptide regulated stimulation of angiogenesis
10/05/2000CA2368489A1 50 human secreted proteins
10/05/2000CA2368482A1 50 human secreted proteins
10/05/2000CA2368477A1 Polynucleotide and deduced amino acid sequences from stromal cells
10/05/2000CA2368469A1 50 human secreted proteins
10/05/2000CA2368467A1 50 human secreted proteins
10/05/2000CA2368442A1 48 human secreted proteins
10/05/2000CA2368376A1 50 human secreted proteins
10/05/2000CA2368374A1 47 human secreted proteins
10/05/2000CA2368302A1 49 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2368233A1 Recombinant neospora antigens and their uses
10/05/2000CA2368113A1 Protozoan expression system
10/05/2000CA2368014A1 Casb619 involved in colon cancers
10/05/2000CA2367901A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
10/05/2000CA2367882A1 Treatment of bone disorders with adrenomedullin or adrenomedullin agonists
10/05/2000CA2367856A1 Analogs of gastric inhibitory peptide and their use for treatment of diabetes
10/05/2000CA2367766A1 Retro-inverso prosaposin-derived peptides and use thereof
10/05/2000CA2367424A1 Hookworm platelet inhibitor
10/05/2000CA2366604A1 Modulators of polysaccharides and uses thereof
10/05/2000CA2366305A1 Method for expressing proteins
10/05/2000CA2366012A1 Methods of treating leukemia
10/05/2000CA2364622A1 Nitrogen mustard compounds and prodrugs therefor
10/05/2000CA2364417A1 Peroral gene therapy of diabetes and obesity
10/05/2000CA2363716A1 49 human secreted proteins
10/05/2000CA2329261A1 Susceptibility to psoriasis
10/05/2000CA2329152A1 Peptide vaccine for canine allergy
10/04/2000EP1041150A1 Hybrid synthetase, fungus/bacterium strain, hybrid peptide and compositions containing same
10/04/2000EP1041149A2 Vaccine and antitoxin for treatment and prevention of C. difficile disease
10/04/2000EP1041147A2 Microtubule-associated protein TPX2
10/04/2000EP1041146A1 Tumor antigen protein, gene thereof, and utilization thereof
10/04/2000EP1041142A2 Universal donor cells
10/04/2000EP1041083A1 Modified timp
10/04/2000EP1040837A2 Medicaments for the treatment of a choroidal neovascularization (CNV) related disorder
10/04/2000EP1040836A1 Immunosuppressant agonists
10/04/2000EP1040835A2 Use of HST-1 in preventing and/or treating tissue damage in cancer therapy
10/04/2000EP1040833A1 Bone resorption suppressing agent
10/04/2000EP1040195A2 Regulatory dna sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof
10/04/2000EP1040194A1 Human signal transduction serine/threonine kinase
10/04/2000EP1040191A2 Rantes mutants and therapeutic applications thereof
10/04/2000EP1040190A1 Serine proteinase inhibitors
10/04/2000EP1040189A1 Polypeptides, their production and use
10/04/2000EP1040187A2 Human protein kinase and kinase inhibitors
10/04/2000EP1040185A2 Neural precursor cells, method for the production and use thereof in neural defect therapy
10/04/2000EP1040126A2 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells
10/04/2000EP1040125A1 Glucose regulated gene
10/04/2000EP1040124A1 Novel abc transporter
10/04/2000EP1040123A2 Human papillomavirus vaccine
10/04/2000EP1040122A1 Protein binding polypeptides
10/04/2000EP1040120A1 Antifungal and antibacterial peptides
10/04/2000EP1040119A2 Hemiasterlin analogs
10/04/2000EP1040118A1 Secreted proteins and polynucleotides encoding them
10/04/2000EP1040117A1 110 human secreted proteins
10/04/2000EP1040096A1 Neuroprotective agents
10/04/2000EP1039934A1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
10/04/2000EP1039933A2 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE AND FOR THE PRODUCTION OF $i(IN VITRO) MABS
10/04/2000EP1039931A1 Multivalent recombinant antibodies for treating hrv infections
10/04/2000EP1039930A2 Adjuvanted vaccine formulation
10/04/2000EP1039929A1 Activated t-cells and their uses
10/04/2000EP1039927A1 UGC (UPSTREAM GENE OF cdsA)
10/04/2000EP1039926A1 Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity
10/04/2000EP1039925A1 Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells
10/04/2000EP1039924A2 Process using the growth factor igf-1 in the manufacture of compositions that are useful in the treatment of cerebellar ataxia
10/04/2000EP1039923A1 Gamma-conopeptides
10/04/2000EP1039922A1 Improved interferon polymer conjugates
10/04/2000EP1039921A1 Substantially pure histidine-linked protein polymer conjugates
10/04/2000EP1039920A1 Fatty acid-acylated insulin analogs
10/04/2000EP1039904A1 Synergistic antimicrobial compositions
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000EP1039886A1 Hiv/fiv protease inhibitors having a small p3 residue
10/04/2000EP1039883A1 Methods for the treatment of apolipoprotein e related diseases
10/04/2000EP1039880A1 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
10/04/2000EP1039874A1 Compositions and methods for treatment of alopecia
10/04/2000EP1039873A1 Keratin-based hydrogel for biomedical applications and method of production
10/04/2000EP1039844A1 Acellular matrix grafts: preparation and use
10/04/2000EP1039843A1 Biodegradable intra vaginal devices
10/04/2000EP1039804A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation
10/04/2000EP0821583B1 Dna vaccines against rotavirus infections
10/04/2000EP0699236B1 Purified mammalian flt3 ligands and agonists and antagonists thereof
10/04/2000CN1268973A Beta-amyloid peptdie-binding proteins and polynucleotides encoding the same
10/04/2000CN1268954A method and compositions for treating abnormal cell growth relating to unwanted guanine nucleotide exchange factor activity
10/04/2000CN1268953A Ligand for herps simplex virus entry mediator and method of use
10/04/2000CN1268891A Dietary supplements contg. natural ingredients
10/04/2000CN1268884A Intra-oral antioxidant prepns.
10/04/2000CN1268517A Liver target high-carbohydrate density galastosyl interferon conjugate
10/04/2000CN1268377A Antimatrix metalloprotease monovalent antibody Fab' medicine conjugate and its tumor-resisting action
10/04/2000CN1268376A Medicine preparation containing glucokinase and its preparation method
10/04/2000CN1268375A Application of hypermnesia peptide in preparation of medicine for curing menopausal syndrome
10/04/2000CN1057125C Five urokinase variant gene and its expression in colibacillus
10/04/2000CN1057124C Bifunctional variants of urokinase with improved fibrinolytic properties and thrombin-inhibiting activity
10/04/2000CN1057121C Method for prepn. of DNA elements for inhibiting growth of non-cancer cells
10/04/2000CN1057119C Reformed human tumor necrosin derivative, and prepn. method therefor
10/04/2000CN1057118C Recombinant C140 receptor
1 ... 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 ... 3163